|
 | Developing and commercializing therapeutics for the treatment of Celiac Sprue | Alvine Pharmaceuticals, Inc.
San Carlos, CA |
|
 | NASDAQ: FOLD | Amicus Therapeutics, Inc. Cranbury, NJ |
|
 | Acquired by Bristol-Myers Squibb Company (NYSE: BMY) | Amira Pharmaceuticals, Inc. San Diego, CA |
|
 | Developing a new generation of nucleic acid-based therapeutics and drug discovery assays through molecular evolution | Archemix Corporation Cambridge, MA |
|
 |
NASDAQ:
AVEO | AVEO Pharmaceuticals, Inc. Cambridge, MA |
|
 | Developing tools that restore spine function and preserve healthy tissue | Baxano, Inc. Mountain View, CA |
|
 | Developing a minimally invasive medical device for office-based fat removal treatments | Cabochon Aesthetics Menlo Park, CA
|
|
|
 | Acquired by J.W. Childs | CHG Healthcare, Inc. Salt Lake City, Utah |
|
 | NASDAQ:
GNOM | Complete Genomics, Inc.
Mountain View, CA |
|
 | Developing and commercializing a medical device system for treating vertebral compression fractures | DFine, Inc. San Jose, CA |
|
 | Acquired by Celgene (NASDAQ: CELG) | Gloucester Pharmaceuticals, Inc. Cambridge, MA |
|
 | NASDAQ: HNSN | Hansen Medical, Inc. Mountain View, CA |
|
 | Acquired by Pfizer Inc. (NYSE: PFE) | Idun Pharmaceuticals, Inc. San Diego, CA |
|
 | NASDAQ: INFI | Infinity Pharmaceuticals, Inc. Cambridge, MA |
|
 | NASDAQ: JAZZ | Jazz Pharmaceuticals, Inc. Palo Alto, CA |
|
 | NASDAQ: KYTH | Kythera Biopharmaceuticals, Inc. Calabasas, CA |
|
 | Developing new drug products for the treatment of ophthalmic diseases | Lux Biosciences Jersey City, NJ |
|
 | Developing nanotechnology enabled products utilizing high performance inorganic nanostructures | Nanosys, Inc. Palo Alto, CA |
|
 | Developing optimized polymer surgical sealants | Neomend, Inc. Irvine, CA |
|
 | Discovering novel factors and developing new therapeutics in the field of metabolic diseases | NGM Biopharmaceuticals, Inc.
South San Francisco, CA |
|
 | Developing innovative, real-time, in vivo pathology devices with an initial focus in gastroenterology | NinePoint Medical, Inc. Cambridge, MA |
|
 | Developing and commercializing novel agents for the treatment of infertility | Nora Therapeutics, Inc.
Palo Alto, CA |
|
 | Acquired by Cytyc Corp. (NASDAQ: HOLX) | Novacept, Inc. Mountain View, CA |
|
 | NASDAQ: NVAX | Novavax, Inc. Rockville, MD |
|
 |
Acquired by ArthoCare Coporation
(NASDAQ: ARTC) | Opus Medical, Inc. Sunnyvale, CA |
|
 | Developing drugs targeting the treatment of inflammatory and respiratory diseases | Panmira
San Diego, CA |
|
 | Developing molecular diagnostic tests for cancer | Pathwork Diagnostics
Sunnyvale, CA |
|
 | Acquired by Almost Family, Inc.
(NASDAQ: AFAM) | PCI Holding Corp.
(aka Patient Care) West Orange, NJ |
|
 | Therapeutics for the treatment and prevention of severe cardiovascular diseases | Portola Pharmaceuticals, Inc. South San Francisco, CA |
|
 | Acquired by Pfizer, Inc. (NYSE: PFE) | Rinat Neuroscience Corp. South San Francisco, CA |
|
 | Acquired by Luitpold Pharmaceuticals | ROXRO Pharma, Inc. Menlo Park, CA |
|
 | Acquired by Helsinn Group | Sapphire Therapeutics, Inc. Bridgewater, NJ |
|
 | Developing innovative therapies for Alzheimer’s disease and other neurodegenerative disorders | Satori Pharmaceuticals, Inc. Cambridge, MA |
|
 | NASDAQ: SNMX | Senomyx, Inc.
San Diego, CA |
|
 | Developing catheter based solutions to address unmet clinical needs | SentreHEART, Inc. Palo Alto, CA |
|
 | Acquired by Eli Lilly and Company (NYSE: LLY) | SGX Pharmaceuticals, Inc. San Diego, CA |
|
 | NASDAQ: SOMX | Somaxon Pharmaceuticals, Inc. San Diego, CA |
|
 | Acquired by Ethicon Endo-Surgery, Inc.,
a Johnson & Johnson Company (NYSE: JNJ) | SurgRx, Inc. Redwood City, CA |
|
 |
Acquired by Ipsen, S.A.
(Euronext: IPN) | Tercica, Inc. Brisbane, CA |
|
 | Developing a new generation of topical drugs for the treatment of fungal infections of the skin and nails | Topica Pharmaceuticals, Inc.
Los Altos, CA |
|
 | Merged with Insmed (NASDAQ: INSM) | Transave Monmouth Junction, NJ |
|
 | Acquired by
Emergent BioSolutions (NYSE: EBS) | Trubion Pharmaceuticals, Inc. Seattle, WA |
|
 | NASDAQ: VNDA | Vanda Pharmaceuticals, Inc Rockville, MD |
|
 | Acquired by
Abbott Laboratories (NYSE: ABT) | Visiogen, Inc. Irvine, CA |
|
 | Discovering, developing and commercializing innovative, high value small molecule medicines | Vitae Pharmaceuticals, Inc. Fort Washington, PA |
